[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

# ![$ucbjy Graphic](https://lunarcrush.com/gi/w:26/t:$ucbjy.png) $ucbjy

$UCBJY sees increased mentions and creator activity, with positive sentiment around clinical trial developments driving engagement.

### About $ucbjy
A cryptocurrency or stock ticker symbol.  

### Insights [#](/topic/$ucbjy/insights)
- $ucbjy creators is up XXX% from the previous week.
- $ucbjy mentions is up XXX% from the previous week.

### Engagements: XXX [#](/topic/$ucbjy/interactions)
---
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/t:$ucbjy/c:line/m:interactions.svg)  
[Engagements 24-Hour Chart Data](/topic/$ucbjy/time-series/interactions.tsv)  
**Current Value**: XXX  
**Daily Average**: XXX  
**1 Month**: XXXXX -XX%  
**1-Year High**: XXXXX on 2025-04-29  
**1-Year Low**: X on 2025-05-10  

| Social Network | X   |
| -------------- | -   |
| Engagements    | XXX |
  

  
  
### Mentions: X [#](/topic/$ucbjy/posts_active)
---
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/t:$ucbjy/c:line/m:posts_active.svg)  
[Mentions 24-Hour Chart Data](/topic/$ucbjy/time-series/posts_active.tsv)  
**Current Value**: X  
**Daily Average**: X  
**1 Week**: X +200%  
**1 Month**: X +13%  
**1-Year High**: X on 2025-04-29  
**1-Year Low**: X on 2025-04-27  

| Social Network | X |
| -------------- | - |
| Mentions       | X |
  

  
  
### Creators: X [#](/topic/$ucbjy/contributors_active)
---
![Creators Line Chart](https://lunarcrush.com/gi/w:600/t:$ucbjy/c:line/m:contributors_active.svg)  
[Creators 24-Hour Chart Data](/topic/$ucbjy/time-series/contributors_active.tsv)  
X unique social accounts have posts mentioning $ucbjy in the last XX hours which is no change from in the previous XX hours
**Daily Average**: X  
**1 Week**: X +100%  
**1 Month**: X +50%  
**1-Year High**: X on 2025-04-29  
**1-Year Low**: X on 2025-04-27  

**Top assets mentioned**
In the posts about $ucbjy in the last XX hours

[Johnson & Johnson (JNJ)](/topic/$jnj)
[Oruka Therapeutics, Inc. Common Stock (ORKA)](/topic/$orka)

**Top topics mentioned**
In the posts about $ucbjy in the last XX hours

[$jnj](/topic/$jnj), [ind](/topic/ind), [$orkas](/topic/$orkas), [$orka](/topic/$orka), [$thrd](/topic/$thrd), [$mrns](/topic/$mrns), [$vrdn](/topic/$vrdn), [$cmrx](/topic/$cmrx), [$prme](/topic/$prme)

### Top Social Posts [#](/topic/$ucbjy/posts)
---
Top posts by engagements in the last XX hours

*Showing only X posts for non-authenticated requests. Use your API key in requests for full results.*

"Stifel reiterated $ORKA Buy-$47 after $ORKA's disclosure of the IND clearance for ORKA-001 and then catching up w/ mgmt. $ABBV $PTGX $JNJ #EADV25 $UCBJY $MLTX Stifel said in its note: "We caught up with management who noted that the IND clearance was based on interim Ph1 data (safety/tolerability) and Ph2a sites are open and actively enrolling -- Ph1 results to be presented at #EADV in September. Recall ORKA-001 is a next-gen IL-23p19 which is designed to explore greater exposure and improved dosing vs. mega-blockbuster Skyrizi based on exploratory IST results in Psoriasis demonstrating"  
[@Quantumup1](/creator/x/Quantumup1) on [X](/post/tweet/1947283589118198123) 2025-07-21 13:12:41 UTC 3524 followers, 2931 engagements


"Citizens reiterated $RAPP Market Outperform-$28 after a KOL call reinforced its confidence in the pot'l for positive RAP-219 Phase X results in focal epilepsy. $PRAX $XENE $BHVN $NBIX $TAK $UCBJY Citizens said in its note: "We recently hosted Dr. Vikram Rao a neurologist from UCSF and epilepsy KOL for a discussion on the upcoming Phase X proof-of-concept results for RAP-219 in focal epilepsy. Dr. Rao is optimistic about the potential for RAP-219 in focal epilepsy due to its validated yet differentiated mechanism of action compelling preclinical results and innovative Phase X trial design."  
[@Quantumup1](/creator/x/Quantumup1) on [X](/post/tweet/1945423685227024482) 2025-07-16 10:02:05 UTC 3524 followers, 1933 engagements